The contrast agent used in the present study (Viscover™ ExiTron™ nano; Miltenyi Biotec, Bergisch-Gladbach, Germany) is an alkaline earth-based nanoparticulate contrast agent specifically formulated for pre-clinical computed tomography imaging. The nanoparticles are sterically stabilized by a polymer coating and have a mean hydrodynamic diameter of 110 nm. Upon i.v. injection, ExiTron nano circulates in the blood stream and is taken up by cells of the reticuloendothelial system (RES), including macrophages within the liver, the so-called Kupffer cells. Two different formulations of the contrast agent are available and both were used in the underlying study: ExiTron nano 6000 (optimized for liver/spleen imaging) and ExiTron nano 12000 (optimized for angiography) with densities of the undiluted contrast agents prior to injection of approx. 6000 HU and approx. 12000 HU, respectively. The injected volume of 100 µl ExiTron nano per mouse (25g) corresponds to a dose equivalent to 640 mg iodine/kg body weight or 1200 mg iodine/kg body weight for ExiTron nano 6000 and ExiTron nano 12000, respectively.
Free full text: Click here